CNBX Pharmaceuticals Inc.

OTCPK:CNBX Stock Report

Market Cap: US$317.3k

CNBX Pharmaceuticals Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Eyal Barad

Chief executive officer

US$253.9k

Total compensation

CEO salary percentage89.3%
CEO tenure6.8yrs
CEO ownershipn/a
Management average tenure5.9yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Eyal Barad's remuneration changed compared to CNBX Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
May 31 2024n/an/a

-US$1m

Feb 29 2024n/an/a

-US$1m

Nov 30 2023n/an/a

-US$4m

Aug 31 2023US$254kUS$227k

-US$4m

May 31 2023n/an/a

-US$4m

Feb 28 2023n/an/a

-US$4m

Nov 30 2022n/an/a

-US$3m

Aug 31 2022US$269kUS$246k

-US$4m

May 31 2022n/an/a

-US$4m

Feb 28 2022n/an/a

-US$5m

Nov 30 2021n/an/a

-US$4m

Aug 31 2021US$269kUS$253k

-US$3m

May 31 2021n/an/a

-US$3m

Feb 28 2021n/an/a

-US$3m

Nov 30 2020n/an/a

-US$3m

Aug 31 2020US$241kUS$222k

-US$7m

May 31 2020n/an/a

-US$8m

Feb 29 2020n/an/a

-US$8m

Nov 30 2019n/an/a

-US$3m

Aug 31 2019US$276kUS$258k

US$1m

May 31 2019n/an/a

US$2m

Feb 28 2019n/an/a

US$1m

Nov 30 2018n/an/a

-US$4m

Aug 31 2018US$207kUS$207k

-US$4m

Compensation vs Market: Eyal's total compensation ($USD253.93K) is below average for companies of similar size in the US market ($USD650.80K).

Compensation vs Earnings: Eyal's compensation has been consistent with company performance over the past year.


CEO

Eyal Barad (59 yo)

6.8yrs

Tenure

US$253,929

Compensation

Mr. Eyal Barad is the Co- Founder of CNBX Pharmaceuticals Inc. (formerly known as Cannabics Pharmaceuticals Inc.) and has been its Chief Executive Officer since January 29, 2018 and Director since November...


Leadership Team

NamePositionTenureCompensationOwnership
Gabriel Yariv
President5.1yrsUS$381.57kno data
Eyal Barad
Co-Founder6.8yrsUS$253.93kno data
Uri Ben-Or
Chief Financial Officer8yrsUS$40.32kno data
Sanja Goldberg
Chief Technology Officer2.3yrsUS$48.12kno data
Noam Permont
Vice President of Public Relations & Investor Relationsno datano datano data
Sigalit Ariely-Portnoy
Senior Advisor of Regulation7.7yrsno datano data
Tal Mofkadi
Financial Advisor & Member of Advisory Boardno datano datano data
Yasha Borstein
Chief Data Officer6.8yrsno datano data
Yaakov Waksman
Head of Cannabidiol Research4.9yrsno datano data
Ilya Reznik
Head of Neuropsychiatry Development3.2yrsno datano data
Lior Eshdat
Member of Scientific Advisory Board & VP of IPno datano datano data

5.9yrs

Average Tenure

59yo

Average Age

Experienced Management: CNBX's management team is seasoned and experienced (5.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gabriel Yariv
President5.1yrsUS$381.57kno data
Eyal Barad
Co-Founder7yrsUS$253.93kno data
Sigalit Ariely-Portnoy
Senior Advisor of Regulation7.7yrsno datano data
Tal Mofkadi
Financial Advisor & Member of Advisory Board7.7yrsno datano data
Lior Eshdat
Member of Scientific Advisory Board & VP of IPno datano datano data
Zamir Halpern
Member of Advisory Board4.6yrsno datano data
Gil Feiler
Head of Advisory Board7.7yrsUS$49.85kno data
Amos Toren
Member of Advisory Board7.7yrsno datano data
Erez Scapa
Member of Advisory Board4.4yrsno datano data
Dana Ben-Ami Shor
Member of Advisory Board4.3yrsno datano data
Caroline Robert
Member of Advisory Board3.3yrsno datano data
Sigal Tavor
Member of Advisory Board3.3yrsno datano data

5.1yrs

Average Tenure

59.5yo

Average Age

Experienced Board: CNBX's board of directors are considered experienced (5.1 years average tenure).